![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Eisai: Antiepileptic Drug Fycompa Regularly Available Again in Germany from December
Eisai Co., Ltd. has announced that its German sales company Eisai GmbH and the National...
ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative...
Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs,...
Elsevier donates Unified Data Model to The Pistoia Alliance, facilitating data sharing and accelerating...
Elsevier, the information analytics business specializing in science and health, has announced it is donating...
Nemera receives Drug Manufacturing Authorization for its Neuenburg plant, in Germany
Nemera received from the German Government Drug Administration (Government Presidium, Tübingen) the Pharmaceutical Drug Manufacturing...
Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies
Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of...
VarmX Announces Publication in Nature Communications of Groundbreaking Snake Venom Inspired Approach to Restore...
VarmX, a Dutch, Leiden based biotech company focusing on the development of therapies in the...
NeuroRx awarded FDA Fast Track Designation for first drug regimen targeting suicide in bipolar...
NeuroRX , Acute Suicidal Ideation and Behavior (ASIB) , NRX-100 (ketamine HCl) , NRX-100 (ketamine...
AstraZeneca and Takeda establish collaboration to develop MEDI1341 for Parkinson’s disease
AstraZeneca and Takeda Pharmaceutical Company Limited announced that they have entered an agreement to jointly...
Driving Patient Engagement in Alzheimer’s Disease Clinical Research to Achieve Trial Success
Worldwide, around 47 million people have dementia, and there are 9.9 million new cases every...
licensure announnced by wuxi biologics and gloria pharmaceuticals of the fully human pd-1 antibody,...
WuXi Biologics a global leadingopen-access biologics technology platform company offering end-to-end solutions for biologicsdiscovery, development...